Resolution of a fungal mycotic aneurysm after a contaminated steroid injection: a case report

In the past ten years there have been three separate outbreaks of fungal contaminated steroid injections from compounding pharmacies. The 2012 outbreak of central nervous system fungal infections associated with contaminated methylprednisolone produced by a United States compounding pharmacy has led...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC research notes 2014-05, Vol.7 (1), p.327-327, Article 327
Hauptverfasser: Nelson, George, Fermo, Olga, Thakur, Kiran, Felton, Elizabeth, Bang, Jee, Wilson, Lucy, Rhee, Susan, Llinas, Rafael, Johnson, Kristine, Sullivan, David
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 327
container_issue 1
container_start_page 327
container_title BMC research notes
container_volume 7
creator Nelson, George
Fermo, Olga
Thakur, Kiran
Felton, Elizabeth
Bang, Jee
Wilson, Lucy
Rhee, Susan
Llinas, Rafael
Johnson, Kristine
Sullivan, David
description In the past ten years there have been three separate outbreaks of fungal contaminated steroid injections from compounding pharmacies. The 2012 outbreak of central nervous system fungal infections associated with contaminated methylprednisolone produced by a United States compounding pharmacy has led to 750 infections (151 with meningitis and paraspinal infections and 325 cases with paraspinal infections without meningitis) and 64 deaths as of October 23, 2013. Exserohilum rostratum has been the predominant pathogen identified by culture, polymerase chain reaction or antibody tests. According to previous reports, cerebral involvement with phaeohyphomycosis has a high risk of morbidity and mortality. We report a 41 year-old Caucasian woman who received a lumbar methylprednisolone injection from a contaminated lot in August 2012. She was diagnosed with fungal meningitis by cerebrospinal fluid pleocytosis and positive (1, 3) beta-D-glucan after cultures and polymerase chain reaction were negative. Two weeks after onset of therapy, she developed a 4.1 mm superior cerebellar artery mycotic aneurysm associated with new stroke symptoms, which resolved with thirty-two weeks of antifungal treatment. This is the rare case report of successful medical management of a cerebral mycotic aneurysm with stroke symptoms related to a presumed phaeohyphomycosis in an immunocompetent individual. Further studies are needed to determine the utility of cerebrospinal fluid (1, 3) beta-D-glucan in diagnosing and monitoring patients with meningitis thought to be related to fungal infection.
doi_str_mv 10.1186/1756-0500-7-327
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4057927</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A540834145</galeid><sourcerecordid>A540834145</sourcerecordid><originalsourceid>FETCH-LOGICAL-b5297-df2f8200643f8ecd955686f9cacc16875db858120fa8352ad25f287cfb4797a63</originalsourceid><addsrcrecordid>eNqNks1rFTEUxQdRbK2u3cmAG7uYNt_JuBBq8aNQKIi6k5DJJM88ZpLXZEb6_nsTX312pIJkkXDvL4fLObeqnkNwAqFgp5BT1gAKQMMbjPiD6nBfeXjnfVA9SWkNAINCwMfVASJCUMjRYfXtk0lhmCcXfB1srWo7-5Ua6nGrw-R0rbyZ4zaNtbKTibmvg5_U6LyaTF-nXAuur51fG100XhdCJVNHswlxelo9smpI5tntfVR9ef_u8_nH5vLqw8X52WXTUdTyprfICpTHI9gKo_uWUiaYbbXSGjLBad8JKiACVglMkeoRtUhwbTvCW64YPqre7HQ3czeaXhs_RTXITXSjilsZlJPLjnff5Sr8kARQ3iKeBd7uBDoX_iGw7OgwymKvLPZKLvEvkVe3U8RwPZs0ydElbYYhmxjmJCElBEDMBfgPFDMmICMFffkXug5z9NnOQglKEGb8D5XDM9J5G_KYuojKM0qAwAQSmqmTe6h8ejO6nKyxLtcXH44XH0r65mZaqTkleXH1dcme7lgdQ0rR2L19EMiyrfcY9uJubHv-93rinyba4us</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1538542367</pqid></control><display><type>article</type><title>Resolution of a fungal mycotic aneurysm after a contaminated steroid injection: a case report</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>SpringerLink Journals - AutoHoldings</source><creator>Nelson, George ; Fermo, Olga ; Thakur, Kiran ; Felton, Elizabeth ; Bang, Jee ; Wilson, Lucy ; Rhee, Susan ; Llinas, Rafael ; Johnson, Kristine ; Sullivan, David</creator><creatorcontrib>Nelson, George ; Fermo, Olga ; Thakur, Kiran ; Felton, Elizabeth ; Bang, Jee ; Wilson, Lucy ; Rhee, Susan ; Llinas, Rafael ; Johnson, Kristine ; Sullivan, David</creatorcontrib><description>In the past ten years there have been three separate outbreaks of fungal contaminated steroid injections from compounding pharmacies. The 2012 outbreak of central nervous system fungal infections associated with contaminated methylprednisolone produced by a United States compounding pharmacy has led to 750 infections (151 with meningitis and paraspinal infections and 325 cases with paraspinal infections without meningitis) and 64 deaths as of October 23, 2013. Exserohilum rostratum has been the predominant pathogen identified by culture, polymerase chain reaction or antibody tests. According to previous reports, cerebral involvement with phaeohyphomycosis has a high risk of morbidity and mortality. We report a 41 year-old Caucasian woman who received a lumbar methylprednisolone injection from a contaminated lot in August 2012. She was diagnosed with fungal meningitis by cerebrospinal fluid pleocytosis and positive (1, 3) beta-D-glucan after cultures and polymerase chain reaction were negative. Two weeks after onset of therapy, she developed a 4.1 mm superior cerebellar artery mycotic aneurysm associated with new stroke symptoms, which resolved with thirty-two weeks of antifungal treatment. This is the rare case report of successful medical management of a cerebral mycotic aneurysm with stroke symptoms related to a presumed phaeohyphomycosis in an immunocompetent individual. Further studies are needed to determine the utility of cerebrospinal fluid (1, 3) beta-D-glucan in diagnosing and monitoring patients with meningitis thought to be related to fungal infection.</description><identifier>ISSN: 1756-0500</identifier><identifier>EISSN: 1756-0500</identifier><identifier>DOI: 10.1186/1756-0500-7-327</identifier><identifier>PMID: 24885172</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Adult ; Aneurysm - complications ; Aneurysm - drug therapy ; Antibodies ; Antifungal Agents - therapeutic use ; Case Report ; Disease control ; Drug therapy ; Exserohilum rostratum ; Female ; Health aspects ; Hospitals ; Humans ; Medical imaging ; Meningitis, Fungal - complications ; Meningitis, Fungal - drug therapy ; Mycoses - complications ; Mycoses - drug therapy ; NMR ; Nuclear magnetic resonance ; Patient outcomes ; Pharmacy ; Stroke (Disease) ; Veins &amp; arteries ; Viral antibodies ; Voriconazole - therapeutic use</subject><ispartof>BMC research notes, 2014-05, Vol.7 (1), p.327-327, Article 327</ispartof><rights>COPYRIGHT 2014 BioMed Central Ltd.</rights><rights>2014 Nelson et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.</rights><rights>Copyright © 2014 Nelson et al.; licensee BioMed Central Ltd. 2014 Nelson et al.; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b5297-df2f8200643f8ecd955686f9cacc16875db858120fa8352ad25f287cfb4797a63</citedby><cites>FETCH-LOGICAL-b5297-df2f8200643f8ecd955686f9cacc16875db858120fa8352ad25f287cfb4797a63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057927/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057927/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24885172$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nelson, George</creatorcontrib><creatorcontrib>Fermo, Olga</creatorcontrib><creatorcontrib>Thakur, Kiran</creatorcontrib><creatorcontrib>Felton, Elizabeth</creatorcontrib><creatorcontrib>Bang, Jee</creatorcontrib><creatorcontrib>Wilson, Lucy</creatorcontrib><creatorcontrib>Rhee, Susan</creatorcontrib><creatorcontrib>Llinas, Rafael</creatorcontrib><creatorcontrib>Johnson, Kristine</creatorcontrib><creatorcontrib>Sullivan, David</creatorcontrib><title>Resolution of a fungal mycotic aneurysm after a contaminated steroid injection: a case report</title><title>BMC research notes</title><addtitle>BMC Res Notes</addtitle><description>In the past ten years there have been three separate outbreaks of fungal contaminated steroid injections from compounding pharmacies. The 2012 outbreak of central nervous system fungal infections associated with contaminated methylprednisolone produced by a United States compounding pharmacy has led to 750 infections (151 with meningitis and paraspinal infections and 325 cases with paraspinal infections without meningitis) and 64 deaths as of October 23, 2013. Exserohilum rostratum has been the predominant pathogen identified by culture, polymerase chain reaction or antibody tests. According to previous reports, cerebral involvement with phaeohyphomycosis has a high risk of morbidity and mortality. We report a 41 year-old Caucasian woman who received a lumbar methylprednisolone injection from a contaminated lot in August 2012. She was diagnosed with fungal meningitis by cerebrospinal fluid pleocytosis and positive (1, 3) beta-D-glucan after cultures and polymerase chain reaction were negative. Two weeks after onset of therapy, she developed a 4.1 mm superior cerebellar artery mycotic aneurysm associated with new stroke symptoms, which resolved with thirty-two weeks of antifungal treatment. This is the rare case report of successful medical management of a cerebral mycotic aneurysm with stroke symptoms related to a presumed phaeohyphomycosis in an immunocompetent individual. Further studies are needed to determine the utility of cerebrospinal fluid (1, 3) beta-D-glucan in diagnosing and monitoring patients with meningitis thought to be related to fungal infection.</description><subject>Adult</subject><subject>Aneurysm - complications</subject><subject>Aneurysm - drug therapy</subject><subject>Antibodies</subject><subject>Antifungal Agents - therapeutic use</subject><subject>Case Report</subject><subject>Disease control</subject><subject>Drug therapy</subject><subject>Exserohilum rostratum</subject><subject>Female</subject><subject>Health aspects</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Medical imaging</subject><subject>Meningitis, Fungal - complications</subject><subject>Meningitis, Fungal - drug therapy</subject><subject>Mycoses - complications</subject><subject>Mycoses - drug therapy</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Patient outcomes</subject><subject>Pharmacy</subject><subject>Stroke (Disease)</subject><subject>Veins &amp; arteries</subject><subject>Viral antibodies</subject><subject>Voriconazole - therapeutic use</subject><issn>1756-0500</issn><issn>1756-0500</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNks1rFTEUxQdRbK2u3cmAG7uYNt_JuBBq8aNQKIi6k5DJJM88ZpLXZEb6_nsTX312pIJkkXDvL4fLObeqnkNwAqFgp5BT1gAKQMMbjPiD6nBfeXjnfVA9SWkNAINCwMfVASJCUMjRYfXtk0lhmCcXfB1srWo7-5Ua6nGrw-R0rbyZ4zaNtbKTibmvg5_U6LyaTF-nXAuur51fG100XhdCJVNHswlxelo9smpI5tntfVR9ef_u8_nH5vLqw8X52WXTUdTyprfICpTHI9gKo_uWUiaYbbXSGjLBad8JKiACVglMkeoRtUhwbTvCW64YPqre7HQ3czeaXhs_RTXITXSjilsZlJPLjnff5Sr8kARQ3iKeBd7uBDoX_iGw7OgwymKvLPZKLvEvkVe3U8RwPZs0ydElbYYhmxjmJCElBEDMBfgPFDMmICMFffkXug5z9NnOQglKEGb8D5XDM9J5G_KYuojKM0qAwAQSmqmTe6h8ejO6nKyxLtcXH44XH0r65mZaqTkleXH1dcme7lgdQ0rR2L19EMiyrfcY9uJubHv-93rinyba4us</recordid><startdate>20140531</startdate><enddate>20140531</enddate><creator>Nelson, George</creator><creator>Fermo, Olga</creator><creator>Thakur, Kiran</creator><creator>Felton, Elizabeth</creator><creator>Bang, Jee</creator><creator>Wilson, Lucy</creator><creator>Rhee, Susan</creator><creator>Llinas, Rafael</creator><creator>Johnson, Kristine</creator><creator>Sullivan, David</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>M7N</scope><scope>5PM</scope></search><sort><creationdate>20140531</creationdate><title>Resolution of a fungal mycotic aneurysm after a contaminated steroid injection: a case report</title><author>Nelson, George ; Fermo, Olga ; Thakur, Kiran ; Felton, Elizabeth ; Bang, Jee ; Wilson, Lucy ; Rhee, Susan ; Llinas, Rafael ; Johnson, Kristine ; Sullivan, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b5297-df2f8200643f8ecd955686f9cacc16875db858120fa8352ad25f287cfb4797a63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Aneurysm - complications</topic><topic>Aneurysm - drug therapy</topic><topic>Antibodies</topic><topic>Antifungal Agents - therapeutic use</topic><topic>Case Report</topic><topic>Disease control</topic><topic>Drug therapy</topic><topic>Exserohilum rostratum</topic><topic>Female</topic><topic>Health aspects</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Medical imaging</topic><topic>Meningitis, Fungal - complications</topic><topic>Meningitis, Fungal - drug therapy</topic><topic>Mycoses - complications</topic><topic>Mycoses - drug therapy</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Patient outcomes</topic><topic>Pharmacy</topic><topic>Stroke (Disease)</topic><topic>Veins &amp; arteries</topic><topic>Viral antibodies</topic><topic>Voriconazole - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nelson, George</creatorcontrib><creatorcontrib>Fermo, Olga</creatorcontrib><creatorcontrib>Thakur, Kiran</creatorcontrib><creatorcontrib>Felton, Elizabeth</creatorcontrib><creatorcontrib>Bang, Jee</creatorcontrib><creatorcontrib>Wilson, Lucy</creatorcontrib><creatorcontrib>Rhee, Susan</creatorcontrib><creatorcontrib>Llinas, Rafael</creatorcontrib><creatorcontrib>Johnson, Kristine</creatorcontrib><creatorcontrib>Sullivan, David</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMC research notes</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nelson, George</au><au>Fermo, Olga</au><au>Thakur, Kiran</au><au>Felton, Elizabeth</au><au>Bang, Jee</au><au>Wilson, Lucy</au><au>Rhee, Susan</au><au>Llinas, Rafael</au><au>Johnson, Kristine</au><au>Sullivan, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Resolution of a fungal mycotic aneurysm after a contaminated steroid injection: a case report</atitle><jtitle>BMC research notes</jtitle><addtitle>BMC Res Notes</addtitle><date>2014-05-31</date><risdate>2014</risdate><volume>7</volume><issue>1</issue><spage>327</spage><epage>327</epage><pages>327-327</pages><artnum>327</artnum><issn>1756-0500</issn><eissn>1756-0500</eissn><abstract>In the past ten years there have been three separate outbreaks of fungal contaminated steroid injections from compounding pharmacies. The 2012 outbreak of central nervous system fungal infections associated with contaminated methylprednisolone produced by a United States compounding pharmacy has led to 750 infections (151 with meningitis and paraspinal infections and 325 cases with paraspinal infections without meningitis) and 64 deaths as of October 23, 2013. Exserohilum rostratum has been the predominant pathogen identified by culture, polymerase chain reaction or antibody tests. According to previous reports, cerebral involvement with phaeohyphomycosis has a high risk of morbidity and mortality. We report a 41 year-old Caucasian woman who received a lumbar methylprednisolone injection from a contaminated lot in August 2012. She was diagnosed with fungal meningitis by cerebrospinal fluid pleocytosis and positive (1, 3) beta-D-glucan after cultures and polymerase chain reaction were negative. Two weeks after onset of therapy, she developed a 4.1 mm superior cerebellar artery mycotic aneurysm associated with new stroke symptoms, which resolved with thirty-two weeks of antifungal treatment. This is the rare case report of successful medical management of a cerebral mycotic aneurysm with stroke symptoms related to a presumed phaeohyphomycosis in an immunocompetent individual. Further studies are needed to determine the utility of cerebrospinal fluid (1, 3) beta-D-glucan in diagnosing and monitoring patients with meningitis thought to be related to fungal infection.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>24885172</pmid><doi>10.1186/1756-0500-7-327</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1756-0500
ispartof BMC research notes, 2014-05, Vol.7 (1), p.327-327, Article 327
issn 1756-0500
1756-0500
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4057927
source MEDLINE; DOAJ Directory of Open Access Journals; PubMed Central Open Access; Springer Nature OA Free Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; SpringerLink Journals - AutoHoldings
subjects Adult
Aneurysm - complications
Aneurysm - drug therapy
Antibodies
Antifungal Agents - therapeutic use
Case Report
Disease control
Drug therapy
Exserohilum rostratum
Female
Health aspects
Hospitals
Humans
Medical imaging
Meningitis, Fungal - complications
Meningitis, Fungal - drug therapy
Mycoses - complications
Mycoses - drug therapy
NMR
Nuclear magnetic resonance
Patient outcomes
Pharmacy
Stroke (Disease)
Veins & arteries
Viral antibodies
Voriconazole - therapeutic use
title Resolution of a fungal mycotic aneurysm after a contaminated steroid injection: a case report
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T23%3A13%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Resolution%20of%20a%20fungal%20mycotic%20aneurysm%20after%20a%20contaminated%20steroid%20injection:%20a%20case%20report&rft.jtitle=BMC%20research%20notes&rft.au=Nelson,%20George&rft.date=2014-05-31&rft.volume=7&rft.issue=1&rft.spage=327&rft.epage=327&rft.pages=327-327&rft.artnum=327&rft.issn=1756-0500&rft.eissn=1756-0500&rft_id=info:doi/10.1186/1756-0500-7-327&rft_dat=%3Cgale_pubme%3EA540834145%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1538542367&rft_id=info:pmid/24885172&rft_galeid=A540834145&rfr_iscdi=true